Efficacy and Safety of Off-Label Use of Fondaparinux in the Management of Heparin-Induced Thrombocytopenia With Thrombosis in an Elderly Woman

被引：2
|
作者：
Leporini, Christian [1 ,2 ]
Rende, Antonio [3 ]
Sorrentino, Alfonso [4 ]
Rizzica, Elvira [5 ]
Russo, Emilio [1 ,2 ]
Gallelli, Luca [1 ,2 ]
De Sarro, Giovambattista [1 ,2 ]
机构：
[1] AO Mater Domini, Ctr Reg Informaz Farmaco, Catanzaro, Italy
[2] Univ Catanzaro, Sch Med, Dept Hlth Sci, Catanzaro, Italy
[3] San Francesco di Paola Hosp, Transfus Med Unit, Rome, Italy
[4] Tor Vergata Univ, Sch Med & Surg, Rome, Italy
[5] San Francesco di Paola Hosp, Farm Osped, Rome, Italy
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 53卷 / 09期
关键词：
HIT; HITT; nadroparin; 4Ts score; Fondaparinux; ADVERSE DRUG-REACTIONS; RETROSPECTIVE ANALYSIS; PATIENT; ANTIBODIES; ULCERATION; HIT;
D O I：
10.1002/jcph.124
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：999 / 1002
页数：4
相关论文
共 50 条
  • [1] Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia
    Schindewolf, Marc
    Steindl, Julia
    Beyer-Westendorf, Jan
    Schellong, Sebastian
    Dohmen, Pascal Maria
    Brachmann, Johannes
    Madlener, Katharina
    Poetzsch, Bernd
    Klamroth, Robert
    Hankowitz, Johannes
    Banik, Norbert
    Eberle, Sonja
    Mueller, Markus Michael
    Kropff, Stefan
    Lindhoff-Last, Edelgard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2636 - 2648
  • [2] Argatroban/bivalirudin/heparinAutoimmune heparin-induced thrombocytopenia, lack of efficacy and off-label use
    Reactions Weekly, 2023, 1986 (1) : 64 - 64
  • [3] Efficacy and Safety of Fondaparinux for the Management of Patients With Heparin-Induced Thrombocytopenia: A Systematic Review
    Ivory, Catherine
    Le Gal, Gregoire
    Carrier, Marc
    Rodger, Marc
    Code, Catherine
    Gandara, Esteban
    CHEST, 2014, 145 (03)
  • [4] Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia
    Snodgrass, Megan N.
    Shields, Jenna
    Rai, Hema
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (08) : 712 - 717
  • [5] Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
    Ciurzynski, Michal
    Jankowski, Krzysztof
    Pietrzak, Bronislawa
    Mazanowska, Natalia
    Rzewuska, Ewa
    Kowalik, Robert
    Pruszczyk, Piotr
    MEDICAL SCIENCE MONITOR, 2011, 17 (05): : CS56 - CS59
  • [6] Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis
    Seculini Patino, Carina E.
    Florencia Pascualini, Maria
    Tabares, Aldo H.
    MEDICINA-BUENOS AIRES, 2015, 75 (05) : 307 - 310
  • [7] Possible use of fondaparinux in heparin-induced thrombocytopenia
    Ashish, Kumar
    Bandyopadhyay, Dhrubajyoti
    Hajra, Adrija
    Ghosh, Raktim K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 256 : 3 - 3
  • [8] Safety and Efficacy of Argatroban in the Management of Heparin-Induced Thrombocytopenia
    Saugel, Bernd
    Schmid, Roland M.
    Huber, Wolfgang
    CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2011, 4 : 11 - 19
  • [9] Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey Continues
    Blackmer, Allison Beck
    Oertel, Maryann D.
    Valgus, John M.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) : 1636 - 1646
  • [10] USE OF FONDAPARINUX IN PATIENTS WITH SUSPECTED HEPARIN-INDUCED THROMBOCYTOPENIA
    Marti Saez, E.
    Novelli Canales, S.
    Mateo Arranz, J.
    Oliver, A.
    Santamaria Ortiz, A.
    Souto Andres, J. C.
    Fontcuberta Boj, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 90 - 91
12345